Shinde, Vivek; Lombard Koen, Anthonet; Hoosain, Zaheer; Archary, Moherndran; Bhorat, Qasim; Fairlie, Lee; Lalloo, Umesh; Masilela, Mduduzi S. L.; Moodley, Dhayendre; Hanley, Sherika; Fouche, Leon Frederik; Louw, Cheryl; Tameris, Michele; Singh, Nishanta; Goga, Ameena; Dheda, Keertan; Grobbelaar, Coert; Joseph, Natasha; Lombaard, Johan J.; Mngqibisa, Rosie; Bhorat, As'ad Ebrahim; Benade, Gabriella; Lalloo, Natasha; Pitsi, Anna; Vollgraaff, Pieter-Louis; Luabeya, Angelique; Esmail, Aliasgar; Petrick, Friedrich G.; Oommen Jose, Aylin; Foulkes, Sharne; Ahmed, Khatija; Thombrayil, Asha; Kalonji, Dishiki; Cloney-Clark, Shane; Zhu, Mingzhu; Bennett, Chijioke; Albert, Gary; Marcheschi, Alex; Plested, Joyce S.; Neal, Susan; Chau, Gordon; Cho, Iksung; Fries, Louis; Glenn, Greg M.; Madhi, Shabir A.

Vaccine pharmacovigilance in South Africa: successes and limitations of current approaches

EXPERT OPINION ON DRUG SAFETY

IF3.1

2024-09-243

PRE

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial

BMC INFECTIOUS DISEASES

IF3

2024-07-201

OAAI

Goga, Ameena; Ramraj, Trisha; Naidoo, Logashvari; Daniels, Brodie; Matlou, Masefetsane; Chetty, Terusha; Dassaye, Reshmi; Ngandu, Nobubelo K.; Galli, Laura; Reddy, Tarylee; Seocharan, Ishen; Ndlangamandla, Qondeni; September, Qholokazi; Ngcobo, Nokwanda; Reddy, Mayuri; Cafun-Naidoo, Tamon; Woeber, Kubashni; Jeenarain, Nitesha; Imamdin, Rabia; Maharajh, Keshnee; Ramjeth, Ashmintha; Bhengu, Thobile; Clarence, Emma; van de Perre, Philippe; Tylleskaer, Thorkild; Nagot, Nicolas; Moles, Jean-Pierre; Moore, Penny L.; Mkhize, Nonhlanhla N.; Gama, Lucio; Dispinseri, Stefania; Biswas, Priscilla; Scarlatti, Gabriella; PedMAbl Cinical Trial Team

Preventing breast milk HIV transmission using broadly neutralizing monoclonal antibodies: One size does not fit all

使用广泛中和的单克隆抗体预防母乳HIV传播: 一种尺寸不适合所有

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2024-03-272

OAAI

Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants

NATURE COMMUNICATIONS

IF15.7

2024-03-056

OAAI

PedMAb1 clinical trial: safety assessment of CAP256V2LS to prevent breastmilk HIV transmission in HIV-1 exposed uninfected neonates

BMJ GLOBAL HEALTH

IF6.1

2023-12-172

Goga, Ameena; Ramraj, Trisha; Naidoo, Logashvari; Matlou, Masefetsane; Daniels, Brodie; Chetty, Terusha; Dassaye, Reshmi; Ngandu, Nobubelo; Galli, Laura; Reddy, Tarylee; Seocharan, Ishen; September, Qholokazi; Ngcobo, Nokwanda; Reddy, Mayuri; Cafun-Naidoo, Tamun; Woeber, Kubashni; Jeenarain, Nitesha; Imamdin, Rabia; Maharajh, Keshnee; Ramjeth, Ashmintha; Bhengu, Thobile; Gama, Lucio; Perre, Philippe Van de; Tylleskar, Thorkild; Nagot, Nicolas; Moles, Jean-Pierre; Moore, Penny; Mkhize, Nonhlanhla N.; Biswas, Priscilla; Scarlatti, Gabriella

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection

PLOS PATHOGENS

IF4.9

2023-11-093

OAAI

ICU experience of the Respiratory Syncytial Virus Season after 2 years into the COVID-19 pandemic in a single instituition

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Mixed-methods cross-sectional study of the prevention of vertical HIV transmission program users unaware of male partner's HIV status, in six South African districts with a high antenatal HIV burden

BMC PUBLIC HEALTH